NEW YORK (GenomeWeb News) – Hologic disclosed after the close of the market Wednesday that it has entered into three credit agreements with Goldman Sachs totaling $2.8 billion and has raised $1 billion through a private placement of senior notes.

The firm, which closed its $3.8 billion acquisition of Gen-Probe earlier in the day, said the funds would be used to pay a portion of the transaction.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.